- Home
- LGHL vs VRAX Comparison
LGHL vs VRAX Comparison
Compare LGHL & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGHL | VRAX |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | Singapore | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 897.5K | 1.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LGHL | VRAX |
|---|---|---|
| Price | $1.26 | $0.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 338.9K | 191.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $0.19 |
| 52 Week High | $8.92 | $1.43 |
Technical Indicators
Market Signals| Indicator | LGHL | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 38.14 |
| Support Level | $1.08 | N/A |
| Resistance Level | $1.94 | $0.25 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 38.46 | 10.22 |
Price Performance
Historical ComparisonAbout LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.